Literature DB >> 19291673

Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.

Masaru Mitsui1, Makiya Nishikawa, Lei Zang, Mitsuru Ando, Kayoko Hattori, Yuki Takahashi, Yoshihiko Watanabe, Yoshinobu Takakura.   

Abstract

BACKGROUND: Nonviral gene transfer generally suffers from short-term expression of transgenes. We have previously demonstrated that plasmids with reduced CpG content exhibited a more prolonged expression of murine interferon (IFN)-beta or IFN-gamma, which was effective in inhibiting metastatic tumor growth. A further extension of the duration of transgene expression could be achieved by controlling the number and location of CpG motifs in plasmid DNA.
METHODS: Luciferase-expressing plasmids with differing CpG content were injected into the tail vein of mice by the hydrodynamic injection method. The effects of CpG content on the duration of transgene expression were examined, focusing on cytosine methylation and pro-inflammatory cytokines. Based on the findings, IFN-gamma-expressing plasmids were constructed and their transgene expression and inhibitory effect on pulmonary metastasis were evaluated.
RESULTS: Plasmids with a few CpG motifs showed a prolonged luciferase activity in the liver. Methylation of CpG motifs in plasmids reduced the expression and the extent of this reduction was greater for plasmids with a high CpG content. Pro-inflammatory cytokines hardly affected the expression. pCpG-Mu gamma, the IFN-gamma-expressing plasmid, which contains 20 CpG motifs only in the cDNA region, exhibited a sustained IFN-gamma concentration at therapeutic levels, and had a great inhibitory effect on the pulmonary metastasis of tumor cells.
CONCLUSIONS: The duration of transgene expression of IFN-gamma was successfully increased by reducing the CpG content of IFN-expressing plasmid vector, which resulted in an increased anticancer activity of IFN gene transfer. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291673     DOI: 10.1002/jgm.1317

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  17 in total

1.  In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats.

Authors:  Jiaxi Chen; Shuyuan Chen; Pintong Huang; Xing-Li Meng; Sandra Clayton; Jin-Song Shen; Paul A Grayburn
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

Review 2.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

3.  PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses.

Authors:  Satoshi Uchida; Keiji Itaka; Qixian Chen; Kensuke Osada; Takehiko Ishii; Masa-Aki Shibata; Mariko Harada-Shiba; Kazunori Kataoka
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

4.  A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.

Authors:  Naoya Miura; Sharif M Shaheen; Hidetaka Akita; Takashi Nakamura; Hideyoshi Harashima
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

5.  Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice.

Authors:  Mitsuru Ando; Yuki Takahashi; Takuma Yamashita; Mai Fujimoto; Makiya Nishikawa; Yoshihiko Watanabe; Yoshinobu Takakura
Journal:  Mol Ther Methods Clin Dev       Date:  2014-06-18       Impact factor: 6.698

6.  Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.

Authors:  Yuki Murakami; Takaaki Ishibashi; Eiichi Tomita; Yukio Imamura; Tomoyuki Tashiro; Kanitta Watcharanurak; Makiya Nishikawa; Yuki Takahashi; Yoshinobu Takakura; Satoko Mitani; Hidetsugu Fujigaki; Yoshiji Ohta; Hisako Kubo; Takayoshi Mamiya; Toshitaka Nabeshima; Hyoung-Chun Kim; Yasuko Yamamoto; Kuniaki Saito
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

7.  A novel micro-linear vector for in vitro and in vivo gene delivery and its application for EBV positive tumors.

Authors:  Hong-Sheng Wang; Zhuo-Jia Chen; Ge Zhang; Xue-Ling Ou; Xiang-Ling Yang; Chris K C Wong; John P Giesy; Jun Du; Shou-Yi Chen
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

8.  Contribution of Epigenetic Modifications to the Decline in Transgene Expression from Plasmid DNA in Mouse Liver.

Authors:  Lei Zang; Makiya Nishikawa; Mitsuru Ando; Yuki Takahashi; Yoshinobu Takakura
Journal:  Pharmaceutics       Date:  2015-08-07       Impact factor: 6.321

9.  DNA ministrings: highly safe and effective gene delivery vectors.

Authors:  Nafiseh Nafissi; Samih Alqawlaq; Eric A Lee; Marianna Foldvari; Paul A Spagnuolo; Roderick A Slavcev
Journal:  Mol Ther Nucleic Acids       Date:  2014-05-27       Impact factor: 10.183

10.  Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells.

Authors:  Nadeeka Bandara; Saliya Gurusinghe; Haiying Chen; Shuangfeng Chen; Le-Xin Wang; Shiang Y Lim; Padraig Strappe
Journal:  Stem Cell Res Ther       Date:  2016-04-01       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.